Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
This sets up the possibility that Medicare beneficiaries could have coverage of GLP-1s for obesity under the Medicare GLP-1 Bridge in the latter half of 2026 and 2027 but then lose access in 2028 if the BALANCE Model or another coverage pathway are not implemented
Aim for balanced meals that incorporate protein, healthy fats, and fiber to support overall digestion, as recommended by our nutritionists
Users are recommended to take 1-2 scoops daily, mixed with 8-16oz of cold water
In the Phase 2 trial at 48 weeks (NEJM 2023): Every single participant on 12 mg lost at least 5% of their body weight
The potential of this peptide does seem compelling
Costs may vary, but generally, Semaglutide tends to be more cost-effective than Tirzepatide
US$ 28.47
US$ 25.18
US$ 24.91
US$ 27.06
US$ 20.45
